Infigratinib and Netupitant: Interaction Details
- Infigratinib
- Truseltiq
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Infigratinib and Netupitant interaction:
Netupitant
We don't have a separate drug information page for Netupitant. The FDA's drug directory lists it as part of Akynzeo (netupitant and palonosetron). Read the Netupitant and Palonosetron drug information page → Have a question about Netupitant? Ask a pharmacist, free →
Infigratinib
- Truseltiq
We don't have a drug information page for Infigratinib yet. Have a question about Infigratinib? Ask a pharmacist, free →
What Happens When You Take Infigratinib With Netupitant
What can happen when they are taken together (rated Major)
Increased infigratinib
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Giving infigratinib, which is a , together with a moderate CYP3A can raise infigratinib plasma concentrations, and this elevation may heighten the likelihood of adverse reactions. The combination should be avoided.1
The Infigratinib and Netupitant Interaction, Explained
Netupitant is part of an anti-nausea medicine (Akynzeo) often used with chemotherapy. Infigratinib (Truseltiq) is a cancer medicine. Your body breaks down infigratinib using an enzyme called , and netupitant can slow that enzyme down. That could let more infigratinib build up in your blood, which may raise the chance of side effects.
This is based on how the drugs work rather than on studies in people, but the labeling still says to avoid combining them. Please don't stop or change anything on your own. Talk with your pharmacist or cancer team, who can decide if another nausea option makes sense and keep a close eye on you.
Mechanism: Netupitant is a moderate . Infigratinib is a , and of its may increase infigratinib exposure (/). Infigratinib is not a that depends on this pathway for activation, so the direction is increased drug effect and toxicity.
- Evidence: theoretical, based on the CYP3A interaction class. No direct clinical data are documented here.
- Severity: major. Onset unspecified.
- Management: avoid per labeling. If an antiemetic is needed, consider an alternative that does not inhibit CYP3A, and monitor for infigratinib adverse reactions if the combination cannot be avoided.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Infigratinib and Netupitant Interact
The likely mechanism
of -mediated infigratinib
How to Manage the Infigratinib and Netupitant Interaction
The documented advice is to avoid using these two medicines together. Your care team will usually look for a different anti-nausea option that does not affect , or review your treatment plan.
- Do not stop or change either medicine on your own.
- Tell your pharmacist and prescriber that you take infigratinib before any nausea medicine is started, especially one containing netupitant (Akynzeo).
- If the combination is truly needed, your team may monitor you more closely and individualize your care.
- Report any new or worsening side effects promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Infigratinib or Netupitant need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Infigratinib and Netupitant: Common Questions
How serious is the Infigratinib and Netupitant interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Infigratinib and Netupitant interaction managed?
The documented advice is to avoid using these two medicines together. Your care team will usually look for a different anti-nausea option that does not affect , or review your treatment plan. Do not stop or change either medicine on your own. Tell your pharmacist and prescriber that you take infigratinib before any nausea medicine is started, especially one containing netupitant (Akynzeo). If… Management is individual — always follow your own care team's guidance.
Does taking Infigratinib and Netupitant at different times of day help?
No. Taking them at different times of day does not prevent this one. Netupitant slows , an enzyme that breaks down infigratinib, so infigratinib can build up in the body. That change lasts while netupitant is being taken and can continue for a while after the last dose.
Your pharmacist or prescriber can tell you how they will manage it.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Infigratinib and Netupitant Interaction
Ask in your own words about taking Infigratinib and Netupitant together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: TRUSELTIQ(TM) oral capsules, infigratinib oral capsules. QED Therapeutics Inc (per FDA), Brisbane, CA, 2021.
Other Serious Interactions of Infigratinib and Netupitant
Also serious with Netupitant
Also serious with Infigratinib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Infigratinib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- GrapeModerate
- + 135 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.